Efficient production of F(ab')2 fragments in mammalian cells
AssigneeCrucell Holland B.V.
InventorsDavid Halford Ashton Jones, Abraham Bout
Life of this patent
Estimating the term…
Abstract
The present invention provides immortalized eukaryotic cells and methods useful for the production of immunologically active bivalent antibody fragments, such as F(ab′)2 fragments. The methods and cells of the invention result in a desirable ratio of bivalent to monovalent antibody fragments.
Claims10
1-24. (canceled)
A process for producing a F(ab′)2 fragment by recombinant expression from a cell in a ratio of at least 1:1 with the corresponding F(ab′) fragment, the process comprising the steps of:
- providing a cell deposited at the European Collection of Cell Cultures (“ECACC”) under number 96022940, said cell further comprising:
- one or more nucleic acids comprising sequences capable of driving expression operably linked to nucleotide sequences encoding F(ab′)2 fragments;
- culturing the cell in a suitable medium;
- and
- expressing the one or more nucleic acids to produce from the cell the F(ab′)2 fragment, wherein the F(ab′)2 fragment and the corresponding F(ab′) fragment are secreted from the cell in a ratio of at least 1:1.
A method for improving the ratio of expressed F(ab′)2 fragments to F(ab′) fragments by recombinant expression from cells as compared to expression from Chinese Hamster Ovary (CHO) cells, the process comprising:
- providing a cell having one or more recombinant nucleic acids comprising sequences capable of driving expression operably linked to nucleotide sequences encoding F(ab′)2 fragments;
- culturing the cell in a suitable medium;
- and
- expressing the one or more nucleic acids to produce from the cell the F(ab′)2 fragment, wherein the cell is a cell deposited at the European Collection of Cell Cultures (“ECACC”) under number 96022940, said cell further comprising the one or more recombinant nucleic acids.
Dependencies are inferred from the claim text.